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INFECTION CONTROL OF CLOSTRIDIUM DIFFICILE INFECTION
Wen-Chien Ko. National Cheng Kung University Hospital, Department of
Internal Medicine, Taiwan
No abstract.
SYMPOSIUM 8 (SP 8)
GLOBAL PREVENTION OF HIV INFECTION IN ADVANCE HAART ERA
SP 8-1
TREATMENT AS PREVENTION: HOW TO MAKE IT WORK?
Kiat Ruxrungtham. Chulalongkorn University
No abstract.
SP 8-2
PRELIMINARY EXPERIENCE OF NON-OCCUPATIONAL POST-EXPOSURE
PROPHYLAXIS (NPEP) IN TAIPEI
Chia-Jui Yang. Attending physician, Division of Infectious diseases,
Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei,
Taiwan
The use of antiretroviral drugs to prevent HIV infection through postexposure
prophylaxis (PEP) has been recommended since zidovudine was first found to
be associated with an 81% reduction in the odds of HIV infection following
percutaneous exposure among healthcare workers in a case-control study over
two decades ago. The concept of PEP was thus applied to non-occupational
exposure such as accidental exposure, noncoercive sex, and sexual assault.
Non-occupational PEP (nPEP) is usually prescribed as a 28-day course of
antiretroviral drugs that should be offered and initiated as early as possible to
all individuals with an exposure that has the potential for HIV transmission,
and ideally within 72 h. The efficacy and use of PEP is supported by data from
animal studies and trials demonstrating reduction of maternaleinfant trans-
mission. Clinical trials from different countries have demonstrated better
tolerability, completion rates, and fewer drugedrug interactions with newer
antiretroviral agents. Notably, there has been a shift from zidovudine-based
to tenofovir-based regimens. In Taiwan, increasing numbers of newly
diagnosed patients with HIV infection via sexual transmission were noted
since 2006. Thus we conducted nPEP as a part of the strategies of HIV
prevention since 2011 in Taipei. NPEP can be viewed as an educable moment
and an opportunity to identify high risk cases. We would like to share our
preliminary experience of nPEP in the prevention of HIV transmission.
SP 8-3
NOSOCOMIAL HIV INFECTIONS - LESSONS FROM HISTORY
Vladmir Krcmery a,b. aSt. Elizabeth University, Institute of Tropical
Medicine, Bratislava, 811 02, Slovakia; bSt. Max Kolbe Pediatric HIV
Institute, C 12334 Phnompenh, Cambodia
Purpose: HIV nosocomial infections in developing countries are extremely
rare due to strict preventive procedures in blood transfusion services super-
vised by government healthcare systems. However, several outbreaks of
nosocomial HIV has been described mainly from developing low or mid in-
come countries within last 20 years.
Methods: At least 3 large HIV nosocomial transmission outbreaks has been re-
ported either by scientific journals but before by themedia and political sources
before, from countries, where HIV and or AIDS is considered as societal or reli-
gious stigma from peoples Jammmaheeria in Lybia in 1999/2008, than from Re-
public of Kazakhstan town Shikment/Cikment in 2005/2007 and in 2011.
Results: 2012 fromRepublic Kyrgizistan, from3hospitals incentral land. Kyrgizi-
stan governmentwas the only onewhich letmedia and international health care
workers tocome inand independently investigate theoutbreaks,andputall chil-
dren (302) onHAART, thereforemore than 90 percent still alive in clinically good
condition. InLybia theoutbreakwasmisusedby thePresidentMuhammarKaddafi
tousepressure toBulgariaandEU,sincebulgariannurseswereaccusedanddeath
sentenced,with thehelp of international diplomacy (Bulgaria,Vatican, Slovakia,
Italy, France, etc) the death sentenced nurses were sent for execution to their
home country ale later released. All children in Benghazi Hospital and MissurataHospital Lybia, in time of our site visit received proper HAART and still alive on
therapy in good clinically condition.Third large outbreak in Kazakhstan city Shik-
mentwas refused tobe site visitedbyWHOorother internal teamandpart of the
children receive therapy but part not and many died. Common cause of those 3
major outbreaks in muslim religion predominant countries despite or relative
high level health care infrastructure have had intra venous drug use history in do-
nors and inadequate HIV testing practices in countries where HIV was not ex-
pected, and non indicated excessive use of blood product in therapy of trivial
ID. Several other small outbreaks of nosocomial HIV mainly in developing coun-
tries of Subsaharan Africa and South East Asia has been reported in 1985/1999
in time of limited diagnosis access and insufficient donor data. However, not
only developing countries has been affected with nosocomial HIV due to inade-
quate syringes supply (eg. Romania 1988).
Conclusions: Despite nosocomial outbreaks of HIV are currently historical
chapters in ID textbooks,lessons from those 4 outbreaks should be still
actual. Vigilance not only in countries with war conflicts and lot of blood
product use is warranted.
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URO-GENITAL INFECTIONSSP 9-1
RISK FACTOR FOR SEXUALLY TRANSMITTED DISEASES
Ryoichi Hamasuna, MD, PhD. Department of Urology, University of
Occupational and Environmental Health, Japan
Sexual intermitted infections (STIs)aretheuniversaldiseases,whicharedescribed
in many old records. Several pathogens for infectious disease can be transmitted
through sexual behaviors. The most popular STIs at the present time are male
urethritis and female cervicitis, which are mainly infected through peno-vaginal
sex between women and men. However, the sexual predilection are exchanged
and the risk factors for infection are also exchanged. STIs are transmittable
betweenmenandmenor femaleandfemale,orbyoral oranal sex. Inaddition, STI
pathogens, such as Neisseria gonorrhoeae or Mycoplasma genitalium have gotten
the antimicrobial resistance.. Especially the antimicrobial resistant of N. gonor-
rhoeaebecomeworldwideproblem.N.gonorrhoeaestrainsareoriginally sensitive
to any antimicrobials. However, the sensitivity for penicillin almost loosed. The
resistant rate against fluoroquinolone, tetracyclineor oral cephalosporin hasbeen
increasing, especially inAsia. It is knownthat thegeneticmutation inN. gonorrhea
strains can be induced by the antimicrobial pressure. In addition, the oral sex is
related to cephalosporin-resistance; N. gonorrhoeae can catch antimicrobial
resistant genomes fromNeisseria specimenswhich has antimicrobial resistance in
the normal flora of the oral cavity. Now, the recommended therapy in any STI
guideline is ceftriaxone injection.However, theceftriaxonehigh-level resistantN.
gonorrhoeae strains emerged from Japan or Europe. This strains were multi-drug
resistance and mutations or transformations on penA gene, which are related to
oral Neisseria species. WHO warned the increase in this untreatable gonorrhea.
The ceftriaxone therapy is still available, but the dosage of ceftriaxone for
gonococcal infection has not determined. High-dose such as 1g of ceftriaxone is
recommended for treatment against both genital and pharyngeal infection, but
somecountries cannot be accepted. Theantimicrobial resistanceofM. genitalium
is also increased. Macrolide-resistant M. genitalium strains increased in the world
and fluoroquinolone-resistant strains emerged. The recommended therapy for M.
genitalium infection has not been confirmed.
SP 9-2
ANTIMICROBIAL RESISTANCE IN URINARY TRACT INFECTIONS e ASIAN
DATA FROM THE GLOBAL PREVALENCE STUDY OF INFECTIONS IN
UROLOGY-GPIU
Seung-Ju Lee a, Hyun Sop Choe a, Yong-Hyun Cho b,*. aDepartment of
Urology, The Catholic University of Korea, St. Vincent’s Hospital, South
Korea; bDepartment of Urology, The Catholic University of Korea, Yeouido
St. Mary’s Hospital, South Korea
We present the Asian antibiotic resistance rates of uropathogens reported in
nosocomial urinary tract infections (NAUTI) during the period of 2004e2013.
Data from the Global Prevalence Study of Infections in Urology (GPIU) from
the period of 2004e2013 were analyzed to evaluate the resistance rates of
S16 Abstracts of the 7th International Congress of the Asia Pacific Society of Infection Control, Taipei, Taiwan, March 26-29, 2015pathogens causing NAUTI. The web-based application was used to record
data of investigators from urology departments participating in the study
every year. Each center entered inpatient data on a single day in the study
periods. The point prevalence data on nosocomial urinary tract infection was
used to find differences among Asian geographic regions.
A total of 659 patients, 436 males (66.2 %) and 223 (33.8 %) females, were
diagnosed with urinary tract infection during the study period. Mean age was
54.9  19.3. Cystitis and pyelonephritis were the most frequent clinical
diagnoses representing 18.4 and 15.0 % respectively. Echerichia coli was
found to be the most frequent uropathogen (171 of 659 isolates) (25.9 %).
Cephalosporins were preferred in 34.4 % of cases followed by fluoroquino-
lones (24.1 %), aminoglycosides (16.8 %), penicillins (7.1 %) and carbapenems
(6.5 %). Resistance rates of fluoroquinolones against proven bacterium were
relatively high (ciprofloxacin 54.9%, levofloxacin 39.0%). Resistance rates of
cephalosporins were more than 42% (42.5w 54.7%). Amikacin and imipenem
were maintaining universal resistant patterns (24.9% and 11.3% respec-
tively). Resistance to almost pathogens was lowest in Middle East Asia.
The resistance rates of most of the uropathogens against the antibiotics
tested show variation by region in Asia. Almost Asian countries have high
resistance rate in broad-spectrum antibiotics inevitably as increasing
antibiotic usage. Knowledge of regional and local resistance data and
prudent use of antibiotics are necessary to optimize antibiotic therapy in
urological patients with NAUTI.SP 9-3
PREVENTION AND CONTROL OF CATHETER ASSOCIATED URINARY TRACT
INFECTION
Paul Anantharajah Tambyah. Department of Medicine, National University
of Singapore, Singapore
Catheter associated Urinary Tract infections are the most common nosoco-
mial infections worldwide. While they are associated with morbidity and
mortality especially when urinary tract obstruction occurs, more impor-
tantly, they are a major reservoir for antimicrobial resistant pathogens.
Several approaches have been attempted to prevent and control CAUTI.
These have been driven by a scientific understanding of the pathogenesis of
the disease but have been hampered by the inability to deal with the biofilm
which develops rapidly once the catheter has been inserted. There has been
a renewed interest in biomaterials but the best material which can prevent
CAUTI in clinical situations has yet to be found. In the interim, the most
successful approaches have been those focusing on process measures
including a number of reminder systems which ensure closed drainage and
reduced duration of catheterization.SYMPOSIUM 10 (SP 10)
VACCINE PREVENTABLE DISEASESSP 10-1
STREPTOCOCCUS PNEUMONIAE
David Greenberg, MD. The Pediatric Infectious Disease Unit, Soroka
University Medical Center, Faculty of Health Sciences, Ben-Gurion
University of the Negev, Beer-Sheva, Israel
The impact of the pneumococcal 7-valent conjugated vaccine (PCV7) on
reduction of invasive pneumococcal disease (IPD) community-acquired
pneumonia (CAP) and acute otitis media (AOM) in children <5 years old
has been reported in various studies. These reductions varied in different
parts of the world, partially due to different endpoints definitions. IPD cases
of the serotypes included in PCV7 declined by more than 90% in the United
States. However, in other countries the reduction was only moderate. A
significant reduction in the number of primary care visits and hospitaliza-
tions due to CAP has been reported from the US. Antibiotic resistant S. pneu-
moniae strains were reported to have decreased significantly in IPD. In
addition, antibiotic use for AOM has dropped significantly.
In countries which introduced the extended 13-valent conjugated vaccine
(PCV13) into the national immunization programs an additional significant
reduction in all pneumococcal related diseases such as IPD were demon-
strated. Moreover, dramatic reductions of 50 to 72% in CAP rates wereobserved after the introduction of PCV13. AOM cases declined significantly
by 60% and pneumococcal AOM by almost 80% with the near elimination of
serotypes included in the PCV13. Indirect protection of the PCVs was also
observed through significant reduction of IPD cases in person >65 years of
age. Finally, significant reduction rates in antibiotic resistant S. pneumoniae
were observed after PCV13 introduction.
As a consequence of PCV13 introduction and its impact, treatment
recommendations for pneumococcal related diseases have been changed
due to reduction in the prevalence of these diseases as well as the reduction
in antibiotic resistance rates.SP 10-2
IMMUNIZATION ACROSS THE LIFESPAN: ADULT VACCINATIONS
Melvin A. Kohn, MD, MSCE . Merck, United States
The world’s population is ageing with life expectancy increasing in most
countries globally. Estimated life expectancy at birth in 2014 in Taiwan is
approximately 80 years. Taiwan’s NDC projects that the percentage of people
> 65will increase fromw12.5% in 2015 tow40.6%, withmedian age increasing
fromw40 years tow58.6 years. An ageing societywill require its population to
remain healthy longer to decrease the burden of illness and remain in the
workforce to maintain self-sufficiency. As a result, preventing disease has
become a higher priority for governments and the public. This includes
reducing the burden of illness due to infectious diseases through immuniza-
tions. Increasingly, governments and healthcare providers have recognized
the importance of immunizations in preventing diseases such as influenza,
pneumococcal disease, herpes zoster, pertussis and others that have a higher
incidence as people age and their natural immunity wanes. Policy makers are
recommending vaccines in the adult population and adding coverage to their
National Immunization Programs. In addition, to expand vaccination opportu-
nities, vaccine providers in many countries now include other health profes-
sionals, such as pharmacists, who are licensed to vaccinate eligible adults.
As well, some countries have adult immunization practice standards that
apply to all healthcare providers, both vaccinators and non-vaccinators.
This presentation will review new developments in the policies and practice
of immunizations targeting the adult population.SP 10-3
TRANSMISSION, OUTCOMES AND VACCINE DEVELOPMENT OF
ENTEROVIRUS 71
Luan-Yin Chang, MD, PhD. Division of Pediatric Infectious Diseases,
Department of Pediatrics, National Taiwan University Hospital, College of
Medicine, National Taiwan University, Taiwan
Enterovirus 71 was first isolated from cases with encephalitis and meningitis in
l969 inCalifornia,USA. Thereafter, several small sporadicoutbreaks occurred in
American, Europe, Japan and Australia. Large epidemic outbreaks with high
mortality rates occurred: in Bulgaria in 1975 with 44 deaths, in Hungary in 1978
with 47 deaths, inMalaysia in 1997with at least 31 deaths, and inTaiwan in 1998
with 78 deaths, recently also in mainland China where hundreds of fatal cases
were found each year and also in Vietnam.
The enterovirus 71 (EV71) outbreak in Taiwan in 1998 is very well-known to
have caused a lot of HFMD, 405 severe and 78 fatal children cases. There
were a lot of questions about this outbreak. Dr. Lu did the seroepidemiology
before and after the 1998 EV71 epidemic in Taipei City, the seroconversion
rate was estimated to be about 10% in young children. Estimation of the
infected children <6 years: 180,000, so severe case rate: 2.2/1000 and
fatality rate: 0.44/1000, about one in two thousand. Among a cohort of 81
children, Lu et al found that the annual EV71 seroconversion rates (3 to 4%)
between 1994 and 1997 were significantly lower than the rate (7 to 11%)
before 1994. It is likely that there was lower incidence of EV71 infection
between 1994 and 1997 and accumulation of susceptible hosts over the
threshold density might have triggered the 1998 outbreak.
From seroepidemiological study, we found the most important places for
children EV71 transmission to be households and daycare centers/kindergar-
tens. We did a prospective family cohort study of EV71 household trans-
mission. The overall enterovirus 71 transmission rate of household contacts
was 52% (176/339): 84% (70/83) for siblings, 83% (19/23) for cousins, 41% (72/
175) for parents, 28% (10/36) for grandparents and 26% (5/19) for uncles/
aunts. Among 87 infected adults, 53% (46/87) were asymptomatic, 39% (34/
